Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing pain management methods for ACL surgery

Official title: Comparison of Preemptive Multimodal Analgesia and Femoral Triangle Block on Early Rehabilitation in ACL Reconstruction: A Prospective, Randomized, Double-Blind Study

Run by Ankara University · NCT06936995 · Data updated 2026-11-12

This study is testing whether a new way of managing pain before ACL surgery works better than a traditional method to help patients recover more comfortably.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment62 (estimated)
SponsorAnkara University
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedJanuary 21, 2025
Main results expectedNovember 25, 2025
Study endsJanuary 20, 2026
Registry record updatedApril 20, 2025
Trial IDNCT06936995 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 scheduled for ACL reconstruction surgery.

Probably not a fit

Patients with a BMI of 30 kg/m² or higher, those with allergies to local anesthetics, or those with chronic pain conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of a preemptive multimodal intravenous analgesia protocol versus a femoral triangle block for managing postoperative pain in patients undergoing anterior cruciate ligament (ACL) reconstruction. Adult patients aged 18 to 65 will be randomly assigned to receive one of the two pain management techniques before surgery. The study will evaluate rehabilitation compliance through various tests and pain scores at multiple postoperative time points, while also assessing secondary outcomes like opioid consumption and side effects. The goal is to determine which method better supports early rehabilitation and reduces pain.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management strategies that enhance rehabilitation outcomes for ACL surgery patients.

How similar studies have gone: Previous studies have shown that multimodal analgesia can lead to better pain control and patient satisfaction compared to single-modality approaches, indicating potential success for this study.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age: 18 years or older. Condition: Patients scheduled for anterior cruciate ligament (ACL) reconstruction surgery.

ASA Classification: Patients classified as ASA I, II, or III. Orientation: Patients who are fully oriented and can cooperate with study procedures.

Consent: Patients capable of providing informed consent to participate in the study.

Exclusion Criteria:

Informed Consent: Patients unable to provide informed consent. BMI: Patients with a BMI of ≥30 kg/m². Allergy: Known allergy to local anesthetics. Orientation and Cooperation: Patients who are not fully oriented or cannot cooperate with study procedures.

Additional Trauma: Patients with other traumatic injuries requiring opioid analgesia.

Neuropathic Pain History: Patients with a history of neuropathic pain. Chronic Pain Syndrome: Patients with a history of chronic pain syndrome.

Where it's running

  • Ankara University Faculty of Medicine
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.